Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ivonescimab
Pancreatic Ductal Adenocarcinoma
AkesoP1CC (43)
Ivosidenib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Institut de Recherches Internationales ServierP1CC (43)
Ivosidenib
Malignant Pancreatic Neoplasm
Case Comprehensive Cancer CenterP1CC (43)
Janx007
Castration-Resistant Prostate Carcinoma
Janux TherapeuticsP1CC (43)
Janx008
Head And Neck Squamous Cell Carcinoma
Janux TherapeuticsP1CC (43)
JL19001
Cancer
Jecho Biopharmaceuticals Co., Ltd.P1CC (43)
JL19001
Non-Hodgkin Lymphoma
Jecho Biopharmaceuticals Co., Ltd.P1CC (43)
Jmkx003948
Renal Cell Carcinoma
JemincareP1CC (43)
jmt106
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P1CC (43)
jmt108
Neoplasm
Conjupro Biotherapeutics, Inc.P1CC (43)
Jnj-101556143
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (43)
Jnj-101556143
Prostate Cancer
Janssen Research & Development, LLCP1CC (43)
Jnj-69086420
Adenocarcinoma
Janssen Research & Development, LLCP1CC (43)
Jnj-75276617
Acute Leukemia
Janssen Research & Development, LLCP1CC (43)
Jnj-89853413
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1CC (43)
Jnj-90009530
B-Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1CC (43)
Jnj-90189892
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1CC (43)
js007
Cancer
Shanghai Junshi Bioscience Co., Ltd.P1CC (43)
JS014
Cancer
Anwita BiosciencesP1CC (43)
js203 for
B-Cell Non-Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd.P1CC (43)
jv-213
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1CC (43)
jv-213
Lymphoma
M.D. Anderson Cancer CenterP1CC (43)
Jwcar201
B-Cell Neoplasm
RenJi HospitalP1CC (43)
Jwcar201
Systemic Lupus Erythematosus
RenJi HospitalP1CC (43)
Jwcar239
Diffuse Large B-Cell Lymphoma
Peking University Cancer Hospital & InstituteP1CC (43)
Showing 2576 to 2600 of 9,928 assets
PreviousPage 104 of 398Next